ANI Pharma Exec Cook Meredith Trims 500 Shares in Routine 10b5‑1 Sale as Stock Slides 4%【News Flash】
Explore how ANI Pharmaceuticals’ recent insider sale by VP Cook Meredith signals disciplined trading, not hidden negative news, and what it means for investors eyeing the 2026 growth plan.
3 minutes to read